礼邦医药(09637.HK)料中期亏损收窄至最多1.78亿人币

阿斯达克财经
Aug 06

礼邦医药-B(09637.HK) 发盈喜,预期截至2026年6月30日止中期收入将介乎约1.03亿至1.06亿元人民币,按年增长约750%至775%;期内录亏损约1.58亿至1.78亿元人民币,较去年同期的2.1亿元人民币亏损收窄。礼邦医药解释,亏损收窄则主要由于公司若干股份的赎回责任已于上市前终止,属一次性因素,期内不再计提相关利息;而收入显著增长主要由于就AP306与R1 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10